Leidos Holdings Stock News

Raymond James Trust N.A. reduced its position in Leidos Holdings, Inc. (NYSE:LDOS) by 12.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 2,277 shares of the aerospace companys stock after selling 320 shares during the period. Raymond James Trust N.A.s holdings in Leidos were worth $219,000 as []

JBJ Investment Partners LLC increased its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 16.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,242 shares of the aerospace companys stock after acquiring an additional 1,992 shares during the quarter. Leidos comprises 0.3% []

Shares of Leidos Holdings, Inc. (NYSE:LDOS) have been given a consensus recommendation of Buy by the ten brokerages that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating, six have issued a buy rating and one has issued a strong []

Leidos Holdings, Inc. (NYSE:LDOS) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 1,230,000 shares, a decline of 30.1% from the October 31st total of 1,760,000 shares. Based on an average daily trading volume, of 713,200 shares, the short-interest ratio is currently 1.7 []

Leidos (LDOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Shares of Leidos Holdings, Inc. (NYSE:LDOS) reached a new 52-week low on Tuesday . The company traded as low as $87.81 and last traded at $87.91, with a volume of 1052946 shares. The stock had previously closed at $90.55. LDOS has been the topic of a number of research reports. Robert W. Baird decreased their []

A sustained downturn in stocks could create new buying opportunities for long-term investors.

Companies covered in narcotics scanner market are Metrohm India Private Limited (India), Smiths Detection Group Ltd (The U.K.), LaserShield Systems Inc. (The U.S.), Aventura Technologies Inc. (The U.S.), Bruker Corporation (The U.S.), Chemring Group PLC (The U.K.), Leidos Holdings, Inc. (The U.S.), Safran SA (France), FLIR Systems Inc. (The U.S.), and more players profiled. Companies covered in narcotics scanner market are Metrohm India Private Limited (India), Smiths Detection Group Ltd (The U.K.), LaserShield Systems Inc. (The U.S.), Aventura Technologies Inc. (The U.S.), Bruker Corporation (The U.S.), Chemring Group PLC (The U.K.), Leidos Holdings, Inc. (The U.S.), Safran SA (France), FLIR Systems Inc. (The U.S.), and more players profiled.

Capital Investment Advisors LLC increased its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 4.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,095 shares of the aerospace companys stock after purchasing an additional 172 shares during the []

Shares of Leidos Holdings, Inc. (NYSE:LDOS) have received a consensus rating of Buy from the ten research firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, six have given a buy recommendation and one has assigned a []

Leidos (NYSE:LDOS) and Reinvent Technology Partners Y (NASDAQ:RTPY) are both aerospace companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings. Profitability This table compares Leidos and Reinvent Technology Partners Ys net margins, return on equity []

Leidos Holdings, Inc. (NYSE:LDOS) was the recipient of a significant drop in short interest in the month of October. As of October 29th, there was short interest totalling 1,760,000 shares, a drop of 16.6% from the October 14th total of 2,110,000 shares. Currently, 1.3% of the companys stock are short sold. Based on an average []

Equities analysts predict that Leidos Holdings, Inc. (NYSE:LDOS) will report sales of $3.57 billion for the current quarter, according to Zacks. Four analysts have provided estimates for Leidos earnings. The highest sales estimate is $3.61 billion and the lowest is $3.53 billion. Leidos reported sales of $3.25 billion during the same quarter last year, which []

Leidos Holdings Inc. (LDOS) CEO Roger Krone on Q3 2021 Results - Earnings Call Transcript

Leidos Holdings (LDOS) Q3 revenues of $3,483 million miss the Zacks Consensus Estimate by 2.8%. The top line improves 7.4% year over year